Cone Beam CT in Assessment of Tibial Bone Defect Healing: an Animal Study
Overview
Authors
Affiliations
Rationale And Objectives: To evaluate cone beam computed tomography (CBCT) for monitoring of tibial bone defect healing in comparison to histopathological findings.
Materials And Methods: Circumscribed tibial bone defects were created in 16 mini-pigs and imaging of the tibia was performed on day 42 using a modern CBCT scanner with flat panel detector (PaX-Duo3D, Vatech, Korea). The extent of osseous consolidation including remaining calcium phosphate granules was measured quantitatively by a CBCT volumetry tool using commercially available software (Osirix Imaging software, Pixmeo, Geneva, Switzerland). Volumes of the entire defect (including all pixels), areas of osseous consolidation (density values >2350) and nonmineralized areas (density values <2350) of the defect were determined. The extent of bone regeneration was determined and correlated with the histomorphometrical reference standard. Independently, a visual semiquantitative CBCT-score was applied (4-point scale) to assess bone defect healing.
Results: The extent of osseous consolidation in CBCT volumetry ranged from 14% to 92% (mean, 63.4 ± 17.6%). There was a significant positive correlation between histologically visible newly formed bone and the extent of bone regeneration on CBCT volumetry (r = 0.74-0.79, P < .001). The visual score matched with the volumetric results in 75% of the cases.
Conclusion: CBCT volumetry allows for reliable, noninvasive quantitative monitoring of bone defect healing and correlates significantly with histological findings. CBCT is a promising technique for imaging of peripheral bones suggesting further evaluation in clinical trials.
Flat-panel conebeam CT in the clinic: history and current state.
Fahrig R, Jaffray D, Sechopoulos I, Stayman J J Med Imaging (Bellingham). 2021; 8(5):052115.
PMID: 34722795 PMC: 8553266. DOI: 10.1117/1.JMI.8.5.052115.
Faccioli N, Santi E, Foti G, Mansueto G, Corain M Musculoskelet Surg. 2020; 106(2):169-177.
PMID: 33211300 PMC: 9130154. DOI: 10.1007/s12306-020-00687-3.
DAngeli G, Messineo D, Riminucci M, Corsi A, Celli M, Vozza I Healthcare (Basel). 2020; 8(4).
PMID: 33008080 PMC: 7711831. DOI: 10.3390/healthcare8040372.
Human iPSC-derived iMSCs improve bone regeneration in mini-pigs.
Jungbluth P, Spitzhorn L, Grassmann J, Tanner S, Latz D, Rahman M Bone Res. 2019; 7:32.
PMID: 31667001 PMC: 6813363. DOI: 10.1038/s41413-019-0069-4.
Bone defect animal models for testing efficacy of bone substitute biomaterials.
Li Y, Chen S, Li L, Qin L, Wang X, Lai Y J Orthop Translat. 2018; 3(3):95-104.
PMID: 30035046 PMC: 5982383. DOI: 10.1016/j.jot.2015.05.002.